| Literature DB >> 28012742 |
Johara Boldrini-França1, Camila Takeno Cologna2, Manuela Berto Pucca3, Karla de Castro Figueiredo Bordon4, Fernanda Gobbi Amorim5, Fernando Antonio Pino Anjolette6, Francielle Almeida Cordeiro7, Gisele Adriano Wiezel8, Felipe Augusto Cerni9, Ernesto Lopes Pinheiro-Junior10, Priscila Yumi Tanaka Shibao11, Isabela Gobbo Ferreira12, Isadora Sousa de Oliveira13, Iara Aimê Cardoso14, Eliane Candiani Arantes15.
Abstract
Snake venoms present a great diversity of pharmacologically active compounds that may be applied as research and biotechnological tools, as well as in drug development and diagnostic tests for certain diseases. The most abundant toxins have been extensively studied in the last decades and some of them have already been used for different purposes. Nevertheless, most of the minor snake venom protein classes remain poorly explored, even presenting potential application in diverse areas. The main difficulty in studying these proteins lies on the impossibility of obtaining sufficient amounts of them for a comprehensive investigation. The advent of more sensitive techniques in the last few years allowed the discovery of new venom components and the in-depth study of some already known minor proteins. This review summarizes information regarding some structural and functional aspects of low abundant snake venom proteins classes, such as growth factors, hyaluronidases, cysteine-rich secretory proteins, nucleases and nucleotidases, cobra venom factors, vespryns, protease inhibitors, antimicrobial peptides, among others. Some potential applications of these molecules are discussed herein in order to encourage researchers to explore the full venom repertoire and to discover new molecules or applications for the already known venom components.Keywords: Drug discovery; Snake venoms; Toxins
Mesh:
Substances:
Year: 2016 PMID: 28012742 DOI: 10.1016/j.bbagen.2016.12.022
Source DB: PubMed Journal: Biochim Biophys Acta Gen Subj ISSN: 0304-4165 Impact factor: 3.770